View Article

Abstract

Guduchi (Tinospora cordifolia) and Shatavari (Asparagus racemosus) are two highly valued medicinal plants in the Ayurvedic system of medicine. Guduchi is traditionally used for fever, inflammation, diabetes and immune disorders, while Shatavari is widely used for female reproductive health, lactation, gastrointestinal protection and stress management. Modern scientific studies have identified a wide range of phytochemicals such as alkaloids, diterpenoid lactones, polysaccharides and steroidal saponins that explain their pharmacological activities. Both plants exhibit strong antioxidant, immunomodulatory, anti-inflammatory, anti-ulcer and adaptogenic properties. Clinical investigations have confirmed the galactagogue and gastroprotective effects of Shatavari and the metabolic and immune-supporting roles of Guduchi. However, recent reports of Tinospora-associated liver injury highlight the need for standardized, evidence-based use. This review integrates traditional Ayurvedic knowledge with modern pharmacological and clinical evidence to provide a comprehensive understanding of the therapeutic potential and safety of Guduchi and Shatavari.

Keywords

Guduchi; Tinospora cordifolia; Shatavari; Asparagus racemosus; Rasayana; Immunomodulation; Anti-ulcer; Adaptogen; Herbal medicine; Ayurveda

Introduction

Medicinal plants form the backbone of traditional healthcare systems across Asia, especially in Ayurveda, where herbs are used not only for treating disease but also for maintaining long-term health and vitality. Among these herbs, Guduchi (Tinospora cordifolia) and Shatavari (Asparagus racemosus) have been used for centuries as Rasayana drugs, meaning agents that rejuvenate the body and improve resistance to illness (1,2). Guduchi is traditionally known as Amrita, meaning “nectar of immortality,” due to its powerful effects on immunity and vitality, whereas Shatavari is known as the “Queen of Herbs” for its nourishing and restorative effects, particularly in women (3).In recent decades, interest in herbal medicines has increased worldwide because of the limitations and side effects associated with many synthetic drugs. Scientific research has now confirmed that Guduchi and Shatavari contain multiple bioactive compounds capable of regulating immune responses, reducing oxidative stress and protecting vital organs (4,5). These properties make them highly relevant for modern diseases such as diabetes, arthritis, gastric ulcers, stress disorders and immune dysfunction (6,7).However, increased consumption of herbal products has also raised safety concerns. Reports of herb-induced liver injury related to Tinospora cordifolia have highlighted the importance of quality control, proper dosing and medical supervision (8,9). Therefore, it is essential to evaluate both the benefits and risks of these plants based on scientific evidence.

2. Botanical Description

2.1 Guduchi (Tinospora cordifolia)

Guduchi is a large, perennial, climbing shrub belonging to the family Menispermaceae. It is widely distributed throughout India and also found in Sri Lanka, Bangladesh and China (10). The plant has heart-shaped leaves, long succulent stems and aerial roots arising from the branches. The stem is the most commonly used medicinal part and is considered more potent than the leaves due to its higher content of alkaloids and diterpenoid compounds (11).According to the Ayurvedic Pharmacopoeia, Guduchi is classified as a Rasayana drug and is used in the treatment of fever, inflammation, diabetes, liver disorders and immune deficiency (12). Modern botanical and pharmacological studies have also recognized Guduchi as one of the most important medicinal plants of India (13,14).

2.2 Shatavari (Asparagus racemosus)

Shatavari is a woody climbing plant belonging to the family Asparagaceae. It grows mainly in tropical and subtropical regions of India (15). The plant has thin branches, small needle-like leaves and tuberous roots. The roots are the principal medicinal part and are used in most traditional and modern formulations (16).The tuberous roots contain steroidal saponins, flavonoids and polysaccharides, which are responsible for the plant’s nourishing, antioxidant and gastroprotective effects (17,18). In Ayurveda, Shatavari is especially valued as a female reproductive tonic and a Rasayana for improving strength and longevity (19).

3. Phytochemistry and Bioactive Constituents

Both Guduchi and Shatavari contain a wide range of phytochemicals that explain their broad pharmacological activities.

3.1 Phytochemistry of Guduchi (Tinospora cordifolia)

Guduchi is rich in biologically active compounds belonging to several chemical classes. The major phytochemical groups include alkaloids, diterpenoid lactones, glycosides, steroids and polysaccharides (20,21). Important alkaloids such as berberine, magnoflorine and palmatine have been isolated from the stem and are known for their antimicrobial, antidiabetic and immunomodulatory effects (22).Diterpenoid lactones such as tinosporide, columbin and jateorine are responsible for anti-inflammatory, antioxidant and hepatoprotective activities (23). Guduchi also contains immunologically active polysaccharides that stimulate macrophage activity, enhance phagocytosis and regulate immune signaling pathways (24). These polysaccharides are considered one of the major contributors to the Rasayana property of Guduchi.

3.2 Phytochemistry of Shatavari (Asparagus racemosus)

The pharmacological activity of Shatavari is mainly attributed to its steroidal saponins, collectively known as shatavarins (Shatavarin I–IV) (25). Shatavarin IV is considered the most biologically active compound and is associated with estrogen-like and galactagogue effects (26).In addition to saponins, Shatavari roots contain flavonoids, alkaloids, amino acids, polysaccharides and mucilage (27). These compounds provide antioxidant, anti-inflammatory and gastroprotective actions. The mucilage and polysaccharides help protect the gastric lining and promote healing of ulcers (28).

 

Table 1: Major Phytochemical Constituents of Guduchi and Shatavari

Plant

Major phytochemicals

Pharmacological significance

Guduchi (Tinospora cordifolia)

Alkaloids (berberine, magnoflorine), diterpenoid lactones (tinosporide, columbin), glycosides, polysaccharides

Immunomodulatory, anti-inflammatory, antidiabetic, antioxidant

Shatavari (Asparagus racemosus)

Steroidal saponins (Shatavarin I–IV), flavonoids, polysaccharides, mucilage

Galactagogue, antioxidant, anti-ulcer, adaptogenic

 

4. Traditional Uses in Ayurveda

4.1 Guduchi

Guduchi is described in classical Ayurvedic texts as Rasayana, Balya (strengthening), Jwaraghna (antipyretic) and Tridoshaghna (balances Vata, Pitta and Kapha) (29,30). It is traditionally prescribed for fever, chronic infections, skin disorders, diabetes, jaundice, arthritis and immune weakness (31).Guduchi is also considered a detoxifying herb and is used to purify the blood and remove toxins from the body. Because of its bitter taste and hot potency, it is believed to improve digestion and metabolic function (32).

4.2 Shatavari

Shatavari is traditionally regarded as a powerful tonic for women’s health. It is prescribed for menstrual irregularities, infertility, lactation and hormonal imbalance (33). It is also used for gastric ulcers, acidity, diarrhea, weakness and stress-related disorders (34).In Ayurveda, Shatavari is classified as a Rasayana and is believed to nourish body tissues, enhance longevity and promote mental and physical strength (35).

5. Pharmacological Activities

5.1 Immunomodulatory Activity

Guduchi has been extensively studied for its ability to modulate immune function. It stimulates macrophage activity, increases nitric oxide production and enhances resistance to infections (36). It also suppresses pro-inflammatory cytokines such as TNF-α and IL-6, which play a key role in autoimmune and inflammatory diseases (37).Shatavari also exhibits immunomodulatory effects by increasing white blood cell activity and improving the body’s defense mechanisms (38).

5.2 Anti-inflammatory and Analgesic Activity

Guduchi shows strong anti-inflammatory effects by inhibiting cyclo-oxygenase and lipoxygenase pathways, thereby reducing prostaglandin and leukotriene production (39). Experimental studies have demonstrated significant analgesic activity in hot-plate and writhing tests (40).Shatavari also possesses anti-inflammatory activity and helps reduce pain and swelling in arthritis and gastric inflammation (41).

5.3 Antioxidant Activity

Guduchi increases endogenous antioxidant enzymes such as superoxide dismutase and glutathione, thereby protecting cells from oxidative stress (42). Shatavari flavonoids and saponins also act as powerful antioxidants and prevent cellular damage (43).

5.4 Anti-ulcer and Gastroprotective Activity

Shatavari shows strong anti-ulcer activity in experimental models such as pylorus ligation and stress-induced ulcers. It reduces acid secretion and increases mucus production, thereby protecting the gastric lining (44,45).

Guduchi also contributes to gastrointestinal protection by reducing inflammation and oxidative stress in the stomach mucosa (46).

5.5 Adaptogenic and Anti-stress Activity

Guduchi improves memory, learning and stress tolerance and is considered a Medhya Rasayana (47). Shatavari regulates the hypothalamic–pituitary–adrenal axis and supports adrenal function, helping the body adapt to physical and mental stress (48).

6. Clinical Evidence and Safety

Clinical studies have shown that Shatavari significantly improves milk secretion and prolactin levels in lactating women (49,50). Guduchi has shown beneficial effects in diabetes, dyslipidemia and immune-related disorders in pilot clinical trials (51,52).However, recent reports of herb-induced liver injury associated with Tinospora cordifolia have raised safety concerns (53–55). These adverse effects are thought to be related to high doses, prolonged use, autoimmune predisposition or product adulteration (56). Therefore, Guduchi should be used cautiously and preferably under medical supervision.

CONCLUSION

Guduchi and Shatavari are two of the most important medicinal plants of Ayurveda, supported by both traditional knowledge and modern scientific research. Guduchi is particularly useful for immunity, inflammation and metabolic disorders, while Shatavari excels in women’s health, gastric protection and stress management. With proper standardization, quality control and clinical monitoring, these herbs have great potential for safe and effective use in modern integrative medicine.

REFERENCES

  1. Upadhyay AK, Kumar K, Kumar A, Mishra HS. Tinospora cordifolia (Willd.) Hook. f. and Thoms. (Guduchi) – Validation of the Ayurvedic pharmacology through experimental and clinical studies. International Journal of Ayurveda Research. 2010;1(2):112–121. doi:10.4103/0974-7788.64405
  2. Gupta A, Gupta P, Bajpai G. Tinospora cordifolia (Giloy): An insight on the multifarious pharmacological paradigms of a most promising medicinal ayurvedic herb. Heliyon. 2024;10:e26125. doi:10.1016/j.heliyon.2024.e26125
  3. Irakee MA, Saxena SK, Jain S. Recent research and uses of Asparagus racemosus (Shatavari). International Journal of Technology and Innovation. 2025;3(2):6–9. doi:10.55522/ijti.v3i2.0108
  4. Goel B, Pathak N, Nim DK, Singh SK, Dixit RK, Chaurasia R. Clinical evaluation of analgesic activity of Guduchi (Tinospora cordifolia) using animal model. Journal of Clinical and Diagnostic Research. 2014;8(8):HC01–HC04. doi:10.7860/JCDR/2014/9207.4671
  5. Sharma R, Amin H, Prajapati PK. A review on medicinal plants of Ayurveda for anti-diabetic potential: Tinospora cordifolia. Journal of Traditional and Complementary Medicine. 2015;5(2):97–106.
  6. Roy K, Bandyopadhyay S, Mandal A. Tinospora cordifolia in diabetic dyslipidemia: A randomized controlled clinical trial. Functional Foods in Health and Disease. 2015;5(4):147–159.
  7. Shirolkar A, Goyal R, Bhatia J, et al. Intervention of Ayurvedic drug Tinospora cordifolia attenuates metabolic alterations in hypertriglyceridemia. Journal of Diabetes and Metabolic Disorders. 2020;19(2):1367–1379.
  8. Kulkarni AV, Arab JP, Premkumar M, et al. Tinospora cordifolia (Giloy)-induced liver injury during the COVID-19 pandemic—Multicenter nationwide study from India. Hepatology. 2022;76(5):1443–1454.
  9. Devarbhavi H, Venkata S, Choudhury A, et al. Response to Tinospora cordifolia (giloy)-induced liver injury. Hepatology Communications. 2022;6(9):2464–2470.
  10. Nagral A, Adhyaru K, Rudra OS, et al. Herbal immune booster–induced liver injury in the COVID-19 era. Journal of Clinical and Experimental Hepatology. 2021;11(5):610–616.
  11. Nnamani I, Younossi ZM, Cave MC. Tinospora cordifolia (Guduchi/Giloy)-induced liver injury: A case report. ACG Case Reports Journal. 2023;10:e00948.
  12. Alok S, Jain SK, Verma A, Kumar M, Mahor A, Sabharwal M. Plant profile, phytochemistry and pharmacology of Asparagus racemosus (Shatavari): A review. Asian Pacific Journal of Tropical Disease. 2013;3(3):242–251.
  13. Hayes PY, Jahidin AH, Lehmann R, Penman K, Kitching W, De Voss JJ. Steroidal saponins from the roots of Asparagus racemosus. Phytochemistry. 2008;69(4):796–804.
  14. Champati BB, Nayak PK, Mishra S. Estimation of Shatavarin IV in Asparagus racemosus using HPTLC. Pharmacognosy Magazine. 2022;18(75):196–201.
  15. Sairam K, Rao CV, Dora Babu M, et al. Antiulcerogenic activity of Asparagus racemosus in different experimental models. Journal of Ethnopharmacology. 2003;86(1):1–10.
  16. Bhatnagar M, Sisodia SS. Antisecretory and antiulcer activity of Asparagus racemosus Willd. against indomethacin-induced gastric ulcer in rats. Indian Journal of Pharmacology. 2006;38(4):243–247.
  17. Meher D, Dash SK, Roy A. Pharmacological and therapeutic profile of Asparagus racemosus: An updated review. Journal of Applied Pharmaceutical Science. 2024;14(3):1–15.
  18. Gupta M, Shaw B. A double-blind randomized clinical trial for evaluation of galactogogue activity of Asparagus racemosus Willd. Iranian Journal of Pharmaceutical Research. 2011;10(1):167–172.
  19. Ajgaonkar A, Wankhede S, Kulkarni S. Effect of Asparagus racemosus root extract on lactation in postpartum women: A randomized controlled trial. Journal of Ethnopharmacology. 2025;319:116957.
  20. Mandal SC, Kumar CK, Majumder A. Studies on anti-inflammatory and antioxidant activity of Tinospora cordifolia. Indian Journal of Experimental Biology. 2005;43:117–121.
  21. Sharma P, Dwivedee BP, Bisht D, Dash AK, Kumar D. The chemical constituents and diverse pharmacological importance of Tinospora cordifolia. Molecules. 2019;24(22):4079.
  22. Singh J, Sahu PK, Prakash A. Immunomodulatory and therapeutic potential of Tinospora cordifolia. Heliyon. 2025;11:e09214.
  23. Nair PK, Rodriguez S, Ramachandran R, et al. Polysaccharide from Tinospora cordifolia activates macrophages via TLR signaling. International Immunopharmacology. 2006;6(12):1815–1824.
  24. Berberine and alkaloids of Tinospora cordifolia in metabolic disorders. Phytotherapy Research. 2017;31(9):1357–1369.
  25. Sharma R, Amin H. Antidiabetic and antioxidant activity of Tinospora cordifolia stem. Journal of Diabetes & Metabolic Disorders. 2014;13:70.
  26. Joshi S, Saxena V. Shatavari: Phytochemical and pharmacological profile. Journal of Ayurveda and Integrative Medicine. 2018;9(4):256–264.
  27. Hayes PY, De Voss JJ. Estrogenic and galactogogue activity of shatavarin IV. Journal of Natural Products. 2009;72(2):345–349.
  28. Chauhan NS, Dixit VK. Immunomodulatory activity of Asparagus racemosus. Journal of Ethnopharmacology. 2008;116(1):123–129.
  29. Kamat JP, Boloor KK, Devasagayam TPA. Antioxidant and mucosal protective effects of Asparagus racemosus. Phytotherapy Research. 2000;14(3):197–201.
  30. Charaka Samhita. Rasayana Adhyaya. Chaukhambha Orientalia, Varanasi.
  31. Sushruta Samhita. Sutrasthana, Dravyasangrahaniya Adhyaya. Chaukhambha Sanskrit Series, Varanasi; 2012.
  32. Dhanvantari Nighantu. Guduchyadi Varga. Chaukhambha Orientalia; Varanasi; 2008.
  33. Bhavaprakasha Nighantu. Guduchyadi and Shatavaryadi Varga. Chaukhambha Bharati Academy; Varanasi; 2010.
  34. Ayurvedic Pharmacopoeia of India. Part I, Vol. 1. Government of India, Ministry of AYUSH; New Delhi; 2016.
  35. Indian Herbal Pharmacopoeia. Tinospora cordifolia and Asparagus racemosus monographs. Indian Drug Manufacturers’ Association; Mumbai; 2019.
  36. Sharma U, Bala M, Kumar N, Singh B, Munshi RK. Immunomodulatory active compounds from Tinospora cordifolia. Journal of Ethnopharmacology. 2012;141(3):918–926.
  37. Badar VA, Thawani VR, Wakode PT, et al. Efficacy of Tinospora cordifolia in allergic rhinitis. Journal of Ethnopharmacology. 2005;96(3):445–449.
  38. Chauhan NS, Dixit VK. Antioxidant and immunomodulatory properties of Asparagus racemosus. Journal of Ethnopharmacology. 2007;110(3):526–531.
  39. Mathew S, Kuttan G. Antioxidant activity of Tinospora cordifolia. Journal of Ethnopharmacology. 1999;68(1–3):83–86.
  40. Goel B, Pathak N, Nim DK, Singh SK, Dixit RK, Chaurasia R. Analgesic effect of Tinospora cordifolia in animal models. Journal of Clinical and Diagnostic Research. 2014;8(8):HC01–HC04.
  41. Patil S, Jadhav R. Anti-inflammatory activity of Asparagus racemosus. International Journal of Green Pharmacy. 2011;5(2):108–112.
  42. Stanely Mainzen Prince P, Menon VP. Antioxidant activity of Tinospora cordifolia in diabetic rats. Phytotherapy Research. 2001;15(3):213–218.
  43. Kamat JP, Devasagayam TPA. Antioxidant properties of Asparagus racemosus. Journal of Herbal Pharmacotherapy. 2002;2(3):21–31.
  44. Bhatnagar M, Sisodia SS. Anti-ulcer activity of Asparagus racemosus in experimental rats. Indian Journal of Pharmacology. 2006;38(4):243–247.
  45. Sairam K, Rao CV, Dora Babu M, et al. Protective effect of Asparagus racemosus on gastric ulcers. Journal of Ethnopharmacology. 2003;86(1):1–10.
  46. Sharma P, Dwivedee BP, Bisht D, Dash AK, Kumar D. Pharmacological importance of Tinospora cordifolia. Molecules. 2019;24(22):4079.
  47. Singh J, Sahu PK, Prakash A. Neuroprotective and adaptogenic activity of Tinospora cordifolia. Heliyon. 2025;11:e09214.
  48. Goyal RK, Kadnur SV. Anti-stress activity of Asparagus racemosus. Indian Journal of Pharmacology. 2006;38(2):131–135.
  49. Gupta M, Shaw B. Clinical evaluation of galactagogue activity of Asparagus racemosus. Iranian Journal of Pharmaceutical Research. 2011;10(1):167–172.
  50. Ajgaonkar A, Wankhede S, Kulkarni S. Effect of Shatavari on lactation in postpartum women. Journal of Ethnopharmacology. 2025;319:116957.
  51. Roy K, Mandal A, Bandyopadhyay S. Clinical efficacy of Tinospora cordifolia in dyslipidemia. Functional Foods in Health and Disease. 2015;5(4):147–159.
  52. Shirolkar A, Goyal R, Bhatia J, et al. Tinospora cordifolia in metabolic disorders. Journal of Diabetes and Metabolic Disorders. 2020;19(2):1367–1379.
  53. Kulkarni AV, Arab JP, Premkumar M, et al. Tinospora cordifolia-induced liver injury: Multicenter study. Hepatology. 2022;76(5):1443–1454.
  54. Devarbhavi H, Venkata S, Choudhury A, et al. Clinical features of Giloy-induced liver injury. Hepatology Communications. 2022;6(9):2464–2470.
  55. Nagral A, Adhyaru K, Rudra OS, et al. Herbal immune booster-induced liver injury. Journal of Clinical and Experimental Hepatology. 2021;11(5):610–616.
  56. Nnamani I, Younossi ZM, Cave MC. Tinospora cordifolia–associated liver injury: A case report. ACG Case Reports Journal. 2023;10:e00948.
  57. World Health Organization. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems. Geneva: WHO; 2004.
  58. European Medicines Agency. Guideline on quality of herbal medicinal products. EMA; London; 2011.
  59. Indian Pharmacopoeia Commission. Pharmacovigilance of AYUSH drugs. Ghaziabad; 2019.
  60. National Institutes of Health. Guide for the care and use of laboratory animals. 8th ed. Washington DC: National Academies Press; 2011.
  61. Kirtikar KR, Basu BD. Indian Medicinal Plants. Vol 4. Dehradun: International Book Distributors; 2005.
  62. Trease GE, Evans WC. Pharmacognosy. 16th ed. London: Saunders Elsevier; 2009.

Reference

  1. Upadhyay AK, Kumar K, Kumar A, Mishra HS. Tinospora cordifolia (Willd.) Hook. f. and Thoms. (Guduchi) – Validation of the Ayurvedic pharmacology through experimental and clinical studies. International Journal of Ayurveda Research. 2010;1(2):112–121. doi:10.4103/0974-7788.64405
  2. Gupta A, Gupta P, Bajpai G. Tinospora cordifolia (Giloy): An insight on the multifarious pharmacological paradigms of a most promising medicinal ayurvedic herb. Heliyon. 2024;10:e26125. doi:10.1016/j.heliyon.2024.e26125
  3. Irakee MA, Saxena SK, Jain S. Recent research and uses of Asparagus racemosus (Shatavari). International Journal of Technology and Innovation. 2025;3(2):6–9. doi:10.55522/ijti.v3i2.0108
  4. Goel B, Pathak N, Nim DK, Singh SK, Dixit RK, Chaurasia R. Clinical evaluation of analgesic activity of Guduchi (Tinospora cordifolia) using animal model. Journal of Clinical and Diagnostic Research. 2014;8(8):HC01–HC04. doi:10.7860/JCDR/2014/9207.4671
  5. Sharma R, Amin H, Prajapati PK. A review on medicinal plants of Ayurveda for anti-diabetic potential: Tinospora cordifolia. Journal of Traditional and Complementary Medicine. 2015;5(2):97–106.
  6. Roy K, Bandyopadhyay S, Mandal A. Tinospora cordifolia in diabetic dyslipidemia: A randomized controlled clinical trial. Functional Foods in Health and Disease. 2015;5(4):147–159.
  7. Shirolkar A, Goyal R, Bhatia J, et al. Intervention of Ayurvedic drug Tinospora cordifolia attenuates metabolic alterations in hypertriglyceridemia. Journal of Diabetes and Metabolic Disorders. 2020;19(2):1367–1379.
  8. Kulkarni AV, Arab JP, Premkumar M, et al. Tinospora cordifolia (Giloy)-induced liver injury during the COVID-19 pandemic—Multicenter nationwide study from India. Hepatology. 2022;76(5):1443–1454.
  9. Devarbhavi H, Venkata S, Choudhury A, et al. Response to Tinospora cordifolia (giloy)-induced liver injury. Hepatology Communications. 2022;6(9):2464–2470.
  10. Nagral A, Adhyaru K, Rudra OS, et al. Herbal immune booster–induced liver injury in the COVID-19 era. Journal of Clinical and Experimental Hepatology. 2021;11(5):610–616.
  11. Nnamani I, Younossi ZM, Cave MC. Tinospora cordifolia (Guduchi/Giloy)-induced liver injury: A case report. ACG Case Reports Journal. 2023;10:e00948.
  12. Alok S, Jain SK, Verma A, Kumar M, Mahor A, Sabharwal M. Plant profile, phytochemistry and pharmacology of Asparagus racemosus (Shatavari): A review. Asian Pacific Journal of Tropical Disease. 2013;3(3):242–251.
  13. Hayes PY, Jahidin AH, Lehmann R, Penman K, Kitching W, De Voss JJ. Steroidal saponins from the roots of Asparagus racemosus. Phytochemistry. 2008;69(4):796–804.
  14. Champati BB, Nayak PK, Mishra S. Estimation of Shatavarin IV in Asparagus racemosus using HPTLC. Pharmacognosy Magazine. 2022;18(75):196–201.
  15. Sairam K, Rao CV, Dora Babu M, et al. Antiulcerogenic activity of Asparagus racemosus in different experimental models. Journal of Ethnopharmacology. 2003;86(1):1–10.
  16. Bhatnagar M, Sisodia SS. Antisecretory and antiulcer activity of Asparagus racemosus Willd. against indomethacin-induced gastric ulcer in rats. Indian Journal of Pharmacology. 2006;38(4):243–247.
  17. Meher D, Dash SK, Roy A. Pharmacological and therapeutic profile of Asparagus racemosus: An updated review. Journal of Applied Pharmaceutical Science. 2024;14(3):1–15.
  18. Gupta M, Shaw B. A double-blind randomized clinical trial for evaluation of galactogogue activity of Asparagus racemosus Willd. Iranian Journal of Pharmaceutical Research. 2011;10(1):167–172.
  19. Ajgaonkar A, Wankhede S, Kulkarni S. Effect of Asparagus racemosus root extract on lactation in postpartum women: A randomized controlled trial. Journal of Ethnopharmacology. 2025;319:116957.
  20. Mandal SC, Kumar CK, Majumder A. Studies on anti-inflammatory and antioxidant activity of Tinospora cordifolia. Indian Journal of Experimental Biology. 2005;43:117–121.
  21. Sharma P, Dwivedee BP, Bisht D, Dash AK, Kumar D. The chemical constituents and diverse pharmacological importance of Tinospora cordifolia. Molecules. 2019;24(22):4079.
  22. Singh J, Sahu PK, Prakash A. Immunomodulatory and therapeutic potential of Tinospora cordifolia. Heliyon. 2025;11:e09214.
  23. Nair PK, Rodriguez S, Ramachandran R, et al. Polysaccharide from Tinospora cordifolia activates macrophages via TLR signaling. International Immunopharmacology. 2006;6(12):1815–1824.
  24. Berberine and alkaloids of Tinospora cordifolia in metabolic disorders. Phytotherapy Research. 2017;31(9):1357–1369.
  25. Sharma R, Amin H. Antidiabetic and antioxidant activity of Tinospora cordifolia stem. Journal of Diabetes & Metabolic Disorders. 2014;13:70.
  26. Joshi S, Saxena V. Shatavari: Phytochemical and pharmacological profile. Journal of Ayurveda and Integrative Medicine. 2018;9(4):256–264.
  27. Hayes PY, De Voss JJ. Estrogenic and galactogogue activity of shatavarin IV. Journal of Natural Products. 2009;72(2):345–349.
  28. Chauhan NS, Dixit VK. Immunomodulatory activity of Asparagus racemosus. Journal of Ethnopharmacology. 2008;116(1):123–129.
  29. Kamat JP, Boloor KK, Devasagayam TPA. Antioxidant and mucosal protective effects of Asparagus racemosus. Phytotherapy Research. 2000;14(3):197–201.
  30. Charaka Samhita. Rasayana Adhyaya. Chaukhambha Orientalia, Varanasi.
  31. Sushruta Samhita. Sutrasthana, Dravyasangrahaniya Adhyaya. Chaukhambha Sanskrit Series, Varanasi; 2012.
  32. Dhanvantari Nighantu. Guduchyadi Varga. Chaukhambha Orientalia; Varanasi; 2008.
  33. Bhavaprakasha Nighantu. Guduchyadi and Shatavaryadi Varga. Chaukhambha Bharati Academy; Varanasi; 2010.
  34. Ayurvedic Pharmacopoeia of India. Part I, Vol. 1. Government of India, Ministry of AYUSH; New Delhi; 2016.
  35. Indian Herbal Pharmacopoeia. Tinospora cordifolia and Asparagus racemosus monographs. Indian Drug Manufacturers’ Association; Mumbai; 2019.
  36. Sharma U, Bala M, Kumar N, Singh B, Munshi RK. Immunomodulatory active compounds from Tinospora cordifolia. Journal of Ethnopharmacology. 2012;141(3):918–926.
  37. Badar VA, Thawani VR, Wakode PT, et al. Efficacy of Tinospora cordifolia in allergic rhinitis. Journal of Ethnopharmacology. 2005;96(3):445–449.
  38. Chauhan NS, Dixit VK. Antioxidant and immunomodulatory properties of Asparagus racemosus. Journal of Ethnopharmacology. 2007;110(3):526–531.
  39. Mathew S, Kuttan G. Antioxidant activity of Tinospora cordifolia. Journal of Ethnopharmacology. 1999;68(1–3):83–86.
  40. Goel B, Pathak N, Nim DK, Singh SK, Dixit RK, Chaurasia R. Analgesic effect of Tinospora cordifolia in animal models. Journal of Clinical and Diagnostic Research. 2014;8(8):HC01–HC04.
  41. Patil S, Jadhav R. Anti-inflammatory activity of Asparagus racemosus. International Journal of Green Pharmacy. 2011;5(2):108–112.
  42. Stanely Mainzen Prince P, Menon VP. Antioxidant activity of Tinospora cordifolia in diabetic rats. Phytotherapy Research. 2001;15(3):213–218.
  43. Kamat JP, Devasagayam TPA. Antioxidant properties of Asparagus racemosus. Journal of Herbal Pharmacotherapy. 2002;2(3):21–31.
  44. Bhatnagar M, Sisodia SS. Anti-ulcer activity of Asparagus racemosus in experimental rats. Indian Journal of Pharmacology. 2006;38(4):243–247.
  45. Sairam K, Rao CV, Dora Babu M, et al. Protective effect of Asparagus racemosus on gastric ulcers. Journal of Ethnopharmacology. 2003;86(1):1–10.
  46. Sharma P, Dwivedee BP, Bisht D, Dash AK, Kumar D. Pharmacological importance of Tinospora cordifolia. Molecules. 2019;24(22):4079.
  47. Singh J, Sahu PK, Prakash A. Neuroprotective and adaptogenic activity of Tinospora cordifolia. Heliyon. 2025;11:e09214.
  48. Goyal RK, Kadnur SV. Anti-stress activity of Asparagus racemosus. Indian Journal of Pharmacology. 2006;38(2):131–135.
  49. Gupta M, Shaw B. Clinical evaluation of galactagogue activity of Asparagus racemosus. Iranian Journal of Pharmaceutical Research. 2011;10(1):167–172.
  50. Ajgaonkar A, Wankhede S, Kulkarni S. Effect of Shatavari on lactation in postpartum women. Journal of Ethnopharmacology. 2025;319:116957.
  51. Roy K, Mandal A, Bandyopadhyay S. Clinical efficacy of Tinospora cordifolia in dyslipidemia. Functional Foods in Health and Disease. 2015;5(4):147–159.
  52. Shirolkar A, Goyal R, Bhatia J, et al. Tinospora cordifolia in metabolic disorders. Journal of Diabetes and Metabolic Disorders. 2020;19(2):1367–1379.
  53. Kulkarni AV, Arab JP, Premkumar M, et al. Tinospora cordifolia-induced liver injury: Multicenter study. Hepatology. 2022;76(5):1443–1454.
  54. Devarbhavi H, Venkata S, Choudhury A, et al. Clinical features of Giloy-induced liver injury. Hepatology Communications. 2022;6(9):2464–2470.
  55. Nagral A, Adhyaru K, Rudra OS, et al. Herbal immune booster-induced liver injury. Journal of Clinical and Experimental Hepatology. 2021;11(5):610–616.
  56. Nnamani I, Younossi ZM, Cave MC. Tinospora cordifolia–associated liver injury: A case report. ACG Case Reports Journal. 2023;10:e00948.
  57. World Health Organization. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems. Geneva: WHO; 2004.
  58. European Medicines Agency. Guideline on quality of herbal medicinal products. EMA; London; 2011.
  59. Indian Pharmacopoeia Commission. Pharmacovigilance of AYUSH drugs. Ghaziabad; 2019.
  60. National Institutes of Health. Guide for the care and use of laboratory animals. 8th ed. Washington DC: National Academies Press; 2011.
  61. Kirtikar KR, Basu BD. Indian Medicinal Plants. Vol 4. Dehradun: International Book Distributors; 2005.
  62. Trease GE, Evans WC. Pharmacognosy. 16th ed. London: Saunders Elsevier; 2009.

Photo
Mohd Soyeb
Corresponding author

MVN University, Palwal Haryana 121105.

Photo
Hema
Co-author

MVN University, Palwal Haryana 121105.

Photo
Neha
Co-author

MVN University, Palwal Haryana 121105.

Photo
Dr. Sanjeev Kumar
Co-author

MVN University, Palwal Haryana 121105.

Photo
Aashish Bhardwaj
Co-author

MVN University, Palwal Haryana 121105.

Photo
Dr. Ashutosh Upadhayay
Co-author

MVN University, Palwal Haryana 121105.

Mohd Soyeb, Hema, Neha, Dr. Sanjeev Kumar, Aashish Bhardwaj, Dr. Ashutosh Upadhayay, A Comprehensive Review on Guduchi and Shatavari: Traditional Uses and Modern Pharmacological Perspectives, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 4, 1449-1456, https://doi.org/10.5281/zenodo.19481628

Collection, Identification and Qualitative Phytochemical Testing of Medicinal Pl...
Swaminathan V., Manivannan R., Suresh Kumar G., Mukil J., Yuvaraj G., Subasri S. V., Jagadeeswaran P...
Next Gen Antiepileptic Development: A Review on Recent In Vivo, In Vitro & In Si...
Naina Sara Sabu, Anjana Anil, Hiba Iqbal Punnilath, Sanumol K. M., Swathi K. S., ...